Beyond the Headlines, Columns-Drugs & Supplements, January 2006

January 6, 2006

SEC Approves Proposed Merger Between J&J and Guidant NEW BRUNSWICK, N.J. - The Securities and Exchange Commission approved on Dec. 28 the revised merger agreement between Johnson & Johnson and Guidant Corp. The merger was approved by J&J's board of directors and Guidant shareholders will vote on Jan. 31. J&J announced on Nov. 15 that it will acquire the company for $21.5 billion, $4.4 billion less than J&J previously offered. J&J and Guidant originally entered into an agreement in December 2004, but the companies revised the agreement after J&J said that recent defibrillator and pacemaker … Subscribe Now Purchase Article for $40.00 Registered User Log In Email Address Password Login Forgot your username or password? UPCOMING CONFERENCES HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone June 27, 2024 - Buffalo, NY The Richardson Hotel Buffalo MORE DETAILS HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates May 29, 2024 - Salt Lake City, UT The Grand America Hotel MORE DETAILS Sign Up For Email Alerts × Email address Publications Asbestos Benzene & Emerging Toxic Torts Litigation Camp Lejeune & Water Contamination Drugs & Medical Devices MDL Mass Tort & Class Action Monitor Reinsurance & Arbitration Talcum Powder Litigation Report Close Submit